Sun Pharmaceuticals Industries Reaches All-Time High Stock Price, Showing Strong Growth Potential
Sun Pharmaceuticals Industries, a leading pharmaceutical company, has reached an all-time high stock price on September 28, 2024. The stock has been performing exceptionally well, outperforming the sector by 1.4% and gaining for the last two consecutive days. With a 1-year performance of 70.94%, it is a promising investment option in the largecap industry.
Sun Pharmaceuticals Industries, a leading pharmaceutical company in the largecap industry, has reached an all-time high stock price on September 28, 2024. This positive news has been met with a 'Buy' call from MarketsMOJO, a trusted source for stock analysis.
The stock has been performing exceptionally well, outperforming the sector by 1.4% and gaining for the last two consecutive days. Today, it hit a new 52-week high of Rs. 1959.35, showing a 4.17% increase in returns. This is a clear indication of the company's strong performance and growth potential.
Intraday trading also saw the stock reach a high of Rs. 1959.35, a 3.21% increase from the previous day. Sun Pharmaceuticals Industries is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further solidifying its strong position in the market.
In comparison to the Sensex performance of 29.42%, Sun Pharmaceuticals Industries has shown an impressive 1-year performance of 70.94%. This showcases the company's consistent growth and success in the pharmaceutical industry.
With its strong financials and consistent performance, Sun Pharmaceuticals Industries is a promising investment option for those looking to invest in the largecap industry. As always, it is important to do your own research and consult with a financial advisor before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
